Product
Lu-177 DOTA-TATE
1 clinical trial
2 indications
Indication
Neuroendocrine TumorsIndication
Neuroendocrine TumorClinical trial
Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014Status: Active (not recruiting), Estimated PCD: 2025-12-01